Case File
efta-02704428DOJ Data Set 11OtherEFTA02704428
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02704428
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
THOMAS MOTTOLA
Sent:
Thursday, January 21, 2016 2:03 PM
To:
JEFFREY EPSTEIN
Subject:
FW: Follow up
Attachments:
A036 - CS 18M SXSE Market Plus 012216.pdf; A037 - CS 18M SPX Market Plus
012216.pdf
Can we talk around 11?
Forwarded Message
D
From: PAUL BARRETT
ate: Thu, 21 Jan
To: Matthew Andrews
Cc: THOMAS MOTTOLA
Subject: RE: Follow up
, Barrett Team <
Matt
Please see attached the termsheets. One is linked to the SPX and one to the=Eurostoxx.
I will call you shortly to walk you through each deal.
Paul
Paul Barrett Manag=ng Director I Global Investment Opportunities Group I J.P. Morgan Securities LLC I J.P. Morgan
Private Bank I =1.P. Morgan Chase Bank N.A.
320 Park Avenue, 14th Floor, New York, NY 10022 I
NOT =N OFFICIAL CONFIRMATION: For informational purposes only. This report does not represent a= official account
of the holdings, balances, or transactions made in your =ccount and is being provided at your request. Please refer to
your m=nthly account statement for the official record of all of your account activities. For question, please call =our J.P.
Morgan representative.
In dis=ussion of options and other strategies, results and risks are based solely=on hypothetical examples cited; actual
results and risks will vary dependi=g on specific circumstances. Investors are urged to consider carefully whether option
or option-related products =n general, as well as the products or strategies discussed herein are suit=ble to their needs.
In actual transactions, the client's counterparty for OTC derivatives applications is JPMorgan Chase Bank, N.A., and
affiliates. For a copy of the "Characteri=tics and Risks of Standardized Options" booklet, please contact your JPM=rgan
Advisor.
This email is confidential and subject to important disclaimers and conditi=ns including on offers for the purchase or sale
of securities, accuracy an= completeness of information, viruses, confidentiality, legal privilege, a=d legal entity
disclaimers, available at http://www.jpmorgan.com/pages/disclosures/email
<http://www.jpmorgan.com/pages/disdo=ures/email> <http://www.jpmorgan.com/pages/disclosures/email
<http://www.jpmorgan.com/pages/disdosur=s/email» .
EFTA_R1_02090417
EFTA02704428
From: Matthew=Andrews
Sent: Wednesday, January 20, 2016 7:10 PM
To: Barrett, Paul S
Cc: THOMAS MOTTOLA
Subject: Follow up
Paul, it was great meeting you today; we are excited to start working with =ou and your team.
Tommy wanted me to follow up with you on the note you referenced in our mee=ing. We would be interested in
reviewing the idea with you and perha=s given the market volatility it is sensible to move quickly on it. =nbsp;
You can reach me on my cell phone or via email to discuss.
Best,
Matt
<http://www.pr=vatecapitaladv.com/ <http://www.privatecapitaladv.com/»
Matthew C. Andrews
Portfolio Manager
150 E. 52nd street, 21st Floor
New York NY 10022
aim: mcaprivcap
www.privatecapitaladv.com <http://www.privatecapitaladv.com/>
This email is confidential and=subject to important disclaimers and conditions including on offers for th= purchase or
sale of securities, accuracy and completeness of inform=tion, viruses, confidentiality, legal privilege, and legal entity
disclaimers, available at http://www.jpmorgan.com/pages/disclosures/email
chttp://ww=jpmorgan.com/pages/disdosures/email>
End of Forwarded Message
2
EFTA_R1_02090418
EFTA02704429
Technical Artifacts (9)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Phone
2704428Phone
2704429SWIFT/BIC
OFFICIALURL
http://www.jpmorgan.com/pages/disclosures/emailURL
http://www.jpmorgan.com/pages/disdo=ures/emailURL
http://www.jpmorgan.com/pages/disdosur=s/emailURL
http://www.pr=vatecapitaladv.comURL
http://www.privatecapitaladv.comWire Ref
referencedRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.